Viskase Holdings, Inc. ENZN
OTC · OOTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1984-02-16
Viskase Holdings, Inc. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $26,000 | — | $26,000 | $701,000 | $52,000 | $207,000 | $6.9M | $8.4M | $8.4M |
| Operating income | -$5.3M | -$1.3M | -$1.0M | -$1.0M | -$469,000 | -$1.3M | -$973,000 | — | — | — |
| Income tax | $19,000 | $347,000 | -$156,000 | -$200,000 | $7,000 | $7,000 | $6,000 | $6,000 | $1.6M | $7.8M |
| Net income | -$3.4M | $778,000 | $1.4M | -$186,000 | -$469,000 | -$1.3M | -$979,000 | $5.8M | $5.4M | -$1.1M |
| EPS (diluted) | $-0.07 | $-0.01 | $0.00 | $-0.02 | $-0.03 | $-0.03 | — | — | $0.12 | $-0.03 |
| Operating cash flow | -$3.0M | $1.1M | $1.3M | -$659,000 | -$501,000 | -$380,000 | $6.9M | -$978,000 | $6.5M | $2.6M |
| Cash & equivalents | $9.2M | $46.9M | $47.0M | $47.0M | $47.6M | $48.1M | $5.4M | $6.5M | $7.5M | $7.6M |
| Inventory | $96.8M | — | — | — | — | — | — | — | — | — |
| Total assets | $402.1M | $47.2M | $47.7M | $47.6M | $47.8M | $48.2M | $6.5M | $15.5M | $9.5M | $11.3M |
| Shareholders' equity | $145.8M | $170.0M | -$3.5M | $3.4M | $4.9M | $7.4M | $6.1M | $15.0M | $9.1M | $10.3M |
Growth · year-over-year · Revenue CAGR -56.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | -96.3% | +1248.1% | -74.9% | -97.0% | -17.4% | +0.0% | -52.0% |
| Net income growth | -538.2% | -43.3% | — | — | — | — | -116.7% | +7.4% | — | -105.2% |
| EPS growth | — | — | — | — | — | — | — | — | — | -106.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000727510 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.